期刊文献+

蚓激酶对缺血性脑血管病恢复期合并高脂血症患者血脂及血液流变学的影响 被引量:4

原文传递
导出
摘要 目的探讨蚓激酶对缺血性脑血管病恢复期合并高脂血症患者血脂及血液流变学的影响。方法 58例缺血性脑血管病恢复期合并高脂血症患者,随机分为治疗组(B组)和对照组(A组)各29例,均予瑞舒伐他汀降脂治疗10mg,qd,B组在此基础上加用蚓激酶60万U,tid。治疗12周后,比较两组治疗前后的差异。结果 B组治疗12周后,全血粘度、血浆粘度、红细胞聚集指数、血浆纤维蛋白原含量及甘油三酯下降均较A组更显著(P<0.01)。结论蚓激酶对缺血性脑血管病患者血脂及血液流变学指标均有不同程度的改善,可应用于缺血性脑血管病的二级预防。
机构地区 武汉市中心医院
出处 《首都医药》 2010年第18期51-52,共2页 Capital Medicine
  • 相关文献

参考文献4

二级参考文献23

  • 1金惠铭,曹翔,张国平,钱睿哲,杨诗春,龚之森,邱少中.龙津对体外血栓形成、凝血及纤维蛋白溶解作用的实验研究[J].微循环技术杂志(临床与实验),1996,4(2):61-62. 被引量:16
  • 2孟家眉.对脑卒中临床研究的建议[J].中华神经精神科杂志,1988,21:60-60. 被引量:49
  • 3The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med, 1995, 333: 1581-1587. 被引量:1
  • 4Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Stroke Study (ECASS). JAMA,1995, 274: 1017-1025. 被引量:1
  • 5Albers GW, Bates VE, Clark WM, et al. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA,2000, 283: 1145-1150. 被引量:1
  • 6Madhavan R, Jacobs BS, Levine SR. Stroke trials: what have we learned? Neurol Res, 2002, 24Suppll : S27-S32. 被引量:1
  • 7Elger B, Hornberger W, Schwarz M, et al. MRI study on delayed ancrod therapy of focal cerebral ischaemia in rats. Eur J Pharmacol,1997, 336: 7-14. 被引量:1
  • 8Hossmann V, Heiss WD, Bewermeyer H, et al. Controlled trial of ancrod in ischemic stroke. Arch Neurol, 1983, 40: 803-808. 被引量:1
  • 9Olinger CP, Brott TG, Barsan WG, et al. Use of ancrod in acute or progressing ischemic cerebral infarction. Ann Emerg Med, 1998,17 : 1208-1209. 被引量:1
  • 10The Ancrod Stroke Study Investigators. Ancrod for the treatment of acute ischemic brain infarction. Stroke, 1994, 25: 1755-1759. 被引量:1

共引文献88

同被引文献40

  • 1毛蕾.蚓激酶对高黏血症患者的血液流变学影响[J].中国医药指南,2008,6(21). 被引量:10
  • 2高政,姜潮,刘启贵.腔隙性脑梗死认知功能障碍的相关危险因素研究[J].中国临床康复,2004,8(19):3704-3706. 被引量:23
  • 3汪涛,郭伟娣,江月仙,竹剑平.蚓激酶治疗高脂血症55例临床疗效观察[J].临床医学,2007,27(4):55-55. 被引量:4
  • 4Kumaraguru U,Gierynska M,Norman S,et al.Immunization with chaperone2peptide complex induces low2avidity cytotoxic T lympho2 cytes providing transient protection against herpes simplex virus infec2 tion[J].JVirol,2002,76(1):136-141. 被引量:1
  • 5Onizuka M,Kazekawa K,Nagata S,et al.Hesignificance of incomplete stent apposition in patients undergoing stenting of internal carotid artery stenosis[J].AJNR Am J Neuroradiol,2006,27(7):1505-1507. 被引量:1
  • 6Ballotta E,Da Giau G,Renon L.Garotid plaque gross mor-phologs and clinical presentation:a prospective study of 457 carotid artery specimens[J].J Surg Res 2000,89(1):78-84. 被引量:1
  • 7Joshi B,Brady K,Lee J,Easley B,et al.Impaired autoregulation of cerebral blood flow during rewarming from hypothermic cardiopulmonary bypass and its potential association with stroke[J].Anesth Analg,2010,110(2):321-328. 被引量:1
  • 8张国平,金惠铭,张明,等.蚂激酶抗凝、纤溶机制及其与组织纤溶酶原激活剂的关系.中华老年医学杂志,1998,17(6):366-369. 被引量:1
  • 9Schonbeck U, Gerdes N, Varo N, et al. Oxidizedlow-density lipo- protein augments and 3-hydroxy-3methylglutaryl coenzyme A re- ductase inhibitorslimitCD40 a nd C1MOL expression in hum a nvascularcells. Circulation ,2002,106 ( 13 ) :2888-2893. 被引量:1
  • 10Iketa U, Shimada K. Statins and monocytes. Lancet, 1999,17 (9) : 1521-1525. 被引量:1

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部